- Patent Title: Methods of treating depression using orexin-2 receptor antagonists
-
Application No.: US17092725Application Date: 2020-11-09
-
Publication No.: US11241432B2Publication Date: 2022-02-08
- Inventor: Peter De Boer , Justine M. Kent , Wayne C. Drevets
- Applicant: Janssen Pharmaceutica NV
- Applicant Address: BE Beerse
- Assignee: Janssen Pharmaceutica NV
- Current Assignee: Janssen Pharmaceutica NV
- Current Assignee Address: BE Beerse
- Agency: BakerHostetler
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61K45/06 ; A61K9/00 ; A61K9/20 ; A61K47/38 ; A61K9/10 ; A61K31/53 ; A61K31/50

Abstract:
The present disclosure is directed to, inter alia, methods of treating a subject suffering from or diagnosed with depression, comprising administering to a subject in need of such treatment an effective amount of a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein R1 to R4 are described herein and wherein the compound is administered prior to sleep.
Public/Granted literature
- US20210052588A1 Methods Of Treating Depression Using Orexin-2 Receptor Antagonists Public/Granted day:2021-02-25
Information query
IPC分类: